ID
11733
Description
The primary objective of this clinical trial is to evaluate safety of switching from fondaparinux to either unfractionated heparin or bivalirudin for patients experiencing acute coronary syndrome undergoing percutaneous coronary angioplasty.
Mots-clés
Versions (2)
- 28/07/2015 28/07/2015 -
- 21/11/2015 21/11/2015 -
Téléchargé le
28 juillet 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Criteria: Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)
Eligibility Criteria
- StudyEvent: ODM
Description
Exclusion criteria
Description
ST elevated myocardial infarction within the preceding 48 hours
Type de données
boolean
Alias
- UMLS CUI-1
- C1536220
Description
Patient weighs more than 400 lbs (181.2 kg) or less than 110 lbs (50 kg)
Type de données
boolean
Alias
- UMLS CUI-1
- C0005910
Description
Patients presenting on or received bivalirudin within the preceding 24 hours;
Type de données
boolean
Alias
- UMLS CUI-1
- C0168273
Description
Patients presenting on or received GP IIb/IIIa inhibitors within the preceding 24 hours;
Type de données
boolean
Alias
- UMLS CUI-1
- C3640054
Description
Patients presenting on or received low-molecular weight heparin within the preceding 24 hours
Type de données
boolean
Alias
- UMLS CUI-1
- C3536766
Description
Patients that received unfractionated heparin less than or equal to 90 minutes prior to fondaparinux administration.
Type de données
boolean
Alias
- UMLS CUI-1
- C2825026
Description
Patients with known conditions of bleeding diathesis
Type de données
boolean
Alias
- UMLS CUI-1
- C3251812
Description
Patients with actively bleeding within the previous 6 months (GI bleed etc.);
Type de données
boolean
Alias
- UMLS CUI-1
- C0019080
Description
Known diagnosis of acute bacterial endocarditis;
Type de données
boolean
Alias
- UMLS CUI-1
- C0014121
Description
Patients with cardiogenic shock
Type de données
boolean
Alias
- UMLS CUI-1
- C0036980
Description
Required intra-aortic balloon pump (IABP)
Type de données
boolean
Alias
- UMLS CUI-1
- C0021860
Description
If patient is on warfarin (Coumadin) therapy
Type de données
boolean
Alias
- UMLS CUI-1
- C0043031
Description
Patients who had a major or minor stroke (CVA or TIA)
Type de données
boolean
Alias
- UMLS CUI-1
- C0559159
Description
Patients who had a major surgery within the past 6 months;
Type de données
boolean
Alias
- UMLS CUI-1
- C0679637
Description
Known impaired renal function (creatinine ≥ 3.0 mg/dL (265.2 μmol/L)
Type de données
boolean
Alias
- UMLS CUI-1
- C0035078
Description
status post renal transplant
Type de données
boolean
Alias
- UMLS CUI-1
- C0022671
Description
patients on chronic dialysis
Type de données
boolean
Alias
- UMLS CUI-1
- C0019004
Description
creatinine clearance ≤ 30 ml/min
Type de données
boolean
Alias
- UMLS CUI-1
- C0373595
Description
A platelet count of less than 100,000 cells/mm3;
Type de données
boolean
Alias
- UMLS CUI-1
- C0032181
Description
Known allergies to fondaparinux, aspirin, clopidogrel bisulfate (PlavixR), ticlopidine (TiclidR), heparin, bivalirudin, that cannot be medically managed;
Type de données
boolean
Alias
- UMLS CUI-1
- C0013182
Description
Known allergies to contrast that cannot be medically managed;
Type de données
boolean
Alias
- UMLS CUI-1
- C0570562
Description
Prior angioplasty within the previous 30 days;
Type de données
boolean
Alias
- UMLS CUI-1
- C3532648
Description
Contraindication to low-molecular weight heparin
Type de données
boolean
Alias
- UMLS CUI-1
- C3536766
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Description
Contraindication to unfractionated heparin
Type de données
boolean
Alias
- UMLS CUI-1
- C2825026
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Description
Contraindication to bivalirudin;
Type de données
boolean
Alias
- UMLS CUI-1
- C0168273
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Description
Pregnant or lactating women;
Type de données
boolean
Alias
- UMLS CUI-1
- C0549206
Description
Pregnant or lactating women;
Type de données
boolean
Alias
- UMLS CUI-1
- C2828358
Description
Currently participating in an investigational drug or another device study.
Type de données
boolean
Alias
- UMLS CUI-1
- C0422740
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)